Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
VA Office of Research and Development
MDMA for AUD/PTSD Comorbidity
Carolina L Haass-Koffler
Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
VA Connecticut Healthcare System
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
University of Iowa
LSD Treatment for Persons With Alcohol Use Disorder
Felix Mueller
ACT_for Alcohol Use Disorder and Depression
Centre hospitalier de l'Université de Montréal (CHUM)
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Johns Hopkins University
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Anders Fink-Jensen, MD, DMSci
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
Peggy C Nopoulos
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Brugmann University Hospital
Psilocybin-assisted Therapy for Alcohol Use Disorder
University of Sydney
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
South West Sydney Local Health District
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
Nathan Brashares Sackett
Inpatient Single Dose Interventions for Alcohol Use Disorder
Denver Health and Hospital Authority
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
University of Sydney
Ketamine for Combined Depression and Alcohol Use Disorder
University Hospital of North Norway
Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism
Healing Advocacy Fund
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Yale University
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Brigham and Women's Hospital
Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)
Clairvoyant Therapeutics
Bristol Imperial MDMA in Alcoholism Study
Imperial College London
Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
University of Zurich
Psilocybin in Alcohol Use Disorder With Comorbid Depression
Centre Hospitalier Universitaire de Nīmes
Ketamine for Reduction of Alcoholic Relapse
University College, London
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
Dr. med. Marcus Herdener
Ketamine for the Treatment for Alcohol Use Disorder in the ED
Brigham and Women's Hospital
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
Keith Heinzerling
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Centre for Addiction and Mental Health
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
VA Office of Research and Development
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
University of Calgary
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Anders Fink-Jensen, MD, DMSci
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
NYU Langone Health
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.